Robert B Jones Acura Pharmaceuticals, Inc (ACUR) insider trading activity

ACUR Quotes by TradingView

Robert B Jones is President & CEO of ACURA PHARMACEUTICALS, INC. Currently has a direct ownership of 643,555 shares of ACUR, which is worth approximately $0. The most recent transaction as insider was on Nov 20, 2023, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 644K
0% 3M change
0% 12M change
Total Value Held $0

Robert B Jones Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2023
BUY
Exercise of conversion of derivative security
-
40,000 Added 5.85%
643,555 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
-
50,000 Added 7.65%
603,555 Common Stock
Aug 03 2022
BUY
Exercise of conversion of derivative security
-
63,666 Added 10.31%
553,555 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
-
63,667 Added 11.5%
489,889 Common Stock
RBJ

Robert B Jones

President & CEO
Palatine, IL

Track Institutional and Insider Activities on ACUR

Follow ACURA PHARMACEUTICALS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACUR shares.

Notify only if

Insider Trading

Get notified when an Acura Pharmaceuticals, Inc insider buys or sells ACUR shares.

Notify only if

News

Receive news related to ACURA PHARMACEUTICALS, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACUR